Ka-Wai Tam, Chi-Tang Ho, Wen-Jui Lee, Shih-Hsin Tu, Ching-Shui Huang, Ching-Shyang Chen, Chia-Hwa Lee, Chih-Hsiung Wu, Yuan-Soon Ho
文献索引:Food Chem. 138(2-3) , 1015-21, (2013)
全文:HTML全文
Breast cancer is the most common malignancy among women and has an age-specific incidence profile. Over the last decade, many studies have demonstrated the anticancer activity of α-tocopherol, the main and most active form of natural vitamin E. α-Tocopherol-associated protein (TAP) was found to be one of the major α-tocopherol binding proteins in human serum and in liver, brain, and prostate tissues. In this study, we found that reduced TAP expression was significantly correlated with Her2/neu receptor expression, breast cancer stage and nodal stage in paired normal and cancerous breast tissue samples from 93 patients using real-time PCR analysis. A cell viability assay showed that α-tocopheryl succinate (α-TOS), a synthetic derivative of α-tocopherol, enhanced the cells' sensitivity to doxorubicin and resulted in a reduction in cell viability in breast cancers. Taken together, these data suggest that the use of vitamin E or its analogue as a dietary supplement may be beneficial for the treatment of cancer.Copyright © 2012 Elsevier Ltd. All rights reserved.